ArticleToxicologic pathology2022

Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1

Yuval Ramot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.